Ignite Creation Date:
2025-12-26 @ 10:59 AM
Ignite Modification Date:
2026-06-02 @ 11:59 PM
Study NCT ID:
NCT00786006
Status:
COMPLETED
Last Update Posted:
2011-12-06
First Post:
2008-11-04
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Randomized Phase II Study of FOLFOX Versus FOLFIRI.3 in Gemcitabine-refractory Pancreatic Cancer
Sponsor:
Asan Medical Center
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Metastatic Pancreatic Cancer | View |